Mechanisms of disease: Infection and spondyloarthritis

Nature Clinical Practice Rheumatology

Volumn 2, Issue 3, 2006, Pages 163-169

  Inman, Robert D ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Bacteria; HLA B27; Infection; Reactive arthritis; Spondyloarthritis

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; HLA B27 ANTIGEN; LYMECYCLINE; PLACEBO;

ANKYLOSING SPONDYLITIS; ANTIGEN DETECTION; ARTHRITIS; CHLAMYDIA; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE PREDISPOSITION; GENETIC LINKAGE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION; MICROBIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW;

ANTI-BACTERIAL AGENTS; ARTHRITIS, REACTIVE; BACTERIAL INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; SPONDYLARTHRITIS;

EID: 33646846845     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0118     Document Type: Review

References (60)

1. Sieper J et al. (2002) Diagnosing reactive arthritis: Role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46: 319-327
2. Fendler C et al. (2001) Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis Ann Rheum Dis 60: 337-343
3. Nikkari S et al. (2001) Use of a peptide based enzyme immunoassay in diagnosis of Chlamydia trachomatis triggered reactive arthritis. J Rheumatol 28: 2487-2493
4. Soderlin MK et al. (2002) Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 61: 911-915
5. Buxton JA et al. (2002) Reactive arthritis and other sequelae following sporadic Salmonella typhimurium infection in British Columbia, Canada: A case control study. J Rheumatol 29: 2154-2158
6. Hannu T et al. (2002) Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis 61: 264-266
7. Locht H et al. (2002) High frequency of reactive joint symptoms after an outbreak of Salmonella enteritidis. J Rheumatol 29: 767-771
8. Hannu T et al. (2002) Campylobacter-triggered reactive arthritis: A population-based study. Rheumatol 41: 312-318
9. Boyer GS et al. (1999) Spondyloarthropathy in the community: Clinical syndromes and disease manifestations in Alaskan Eskimo populations. J Rheumatol 26: 1537-1544
10. Rudwaleit M et al. (2001) Low incidence of reactive arthritis in children following a Salmonella outbreak. Ann Rheum Dis 60: 1055-1057
11. Taurog JD et al. (1994) The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180: 2359-2964
12. Colmegna I et al. (2004) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 17: 348-369
13. Soderlin MK et al. (2003) Infections preceding early arthritis in southern Sweden: A prospective population-based study. J Rheumatol 30: 459-464
14. Gerard HC et al. (1998) Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 25: 734-742
15. Kuipers JG et al. (1998) Detection of Chlamydia trachomatis in peripheral blood leukocytes of reactive arthritis patients by polymerase chain reaction. Arthritis Rheum 41: 1894-1895
16. Schumacher HR Jr et al. (1988) Light and electron microscopic studies on the synovial membrane in Reiter's syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum 31: 937-946
17. Kuipers JG et al. (2003) How does Chlamydia cause arthritis? Rheum Dis Clin North Am 29: 613-629
18. Morrison RP (2003) New insights into a persistent problem - chlamydial infections. J Clin Invest 111: 1647-1649
19. Zeidler H et al. (2004) Chlamydia-induced arthritis. Curr Opin Rheumatol 16: 380-392
20. Tse SM et al. (2005) Accumulation of diacylglycerol in the Chlamydia inclusion vacuole: Possible role in the inhibition of host cell apoptosis. J Biol Chem 280: 25210-25215
21. Jendro MC et al. (2004) Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-alpha in vitro. Med Microbiol Immunol 193: 45-52
22. Chen T et al. (2003) Bacterial components in the synovial tissue of patients with advanced rheumatoid arthritis or osteoarthritis: Analysis with gas chromatography-mass spectrometry and pan-bacterial polymerase chain reaction. Arthritis Rheum 49: 328-334
23. Zhang X et al. (2003) Microbe hunting in the joints. Arthritis Rheum 49: 479-482
24. Stone MA et al. (2004) Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumoniae in the pathogenesis of familial ankylosing spondylitis. Rheumatol 43: 148-155
25. Katona IM et al. (1991) Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators. J Immunol 146: 708-714
26. Zhang X et al. (2004) Synovial fibroblasts infected with Salmonella enterica serovar typhimurium mediate osteoclast differentiation and activation. Infec Immun 72: 7183-7189
27. H2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 42: 2039-44
28. Anttonen K et al. Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis. Time course in adherent and non-adherent cultures. Ann Rheum Dis, in press
29. Ekman P et al. (2002) HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines. Infect Immun 70: 1609-1614
30. Penttinen MA et al. (2002) HLA-B27 modulates nuclear factor kappaB activation in human monocytic cells exposed to lipopolysaccharide. Arthritis Rheum 46: 2172-2180
31. Penttinen MA et al. (2004) Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: dependency on glutamic acid at position 45 in the B pocket of HLA-B27. Arthritis Rheum 50: 2255-2263
32. Young JL et al. (2001) HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines. Infect Immun 69: 6670-6675
33. Inman RD and Payne U (2003) Determinants of synoviocyte clearance of arthritogenic bacteria. J Rheumatol 30: 1291-1297
34. Ringrose JH et al. (2004) Major histocompatibility complex class I peptide presentation after Salmonella enterica serovar typhimurium infection assessed via stable isotope tagging of the B27-presented peptide repertoire. Infec Immun 72: 5097-5105
35. + synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis. Int Immunol 14: 471-479
36. Ren EC et al. (1997) Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens 49: 67-69
37. D'Amato M et al. (1995) Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 25: 3199-3201
38. Fiorillo MT et al. (1998) The naturally occurring polymorphism Asp116→His116, differentiating the ankylosing spondylitis-associated HLA-B*2705 from the non-associated HLA-B*2709 subtype, influences peptide-specific CD8 T cell recognition. Eur J Immunol 28: 2508-2516
39. Ugrinovic S et al. (1997) A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J Immunol 159: 5715-5723
40. Ackermann B et al. (1997) Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: A contribution to the self-limitation of cellular immune reactions in reactive arthritis? J Infect Dis 175: 1121-1127
41. Kuon W et al. (2001) Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases. J Immunol 167: 4738-4746
42. Appel H et al. (2004) Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res Ther 6: R521-34
43. Lopez-Larrea C et al. (1998) The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. Mol Med Today 4: 540-549
44. Williams RC et al. (1992) Molecular mimicry, ankylosing spondylitis and reactive arthritis - something missing? Scand J Rheumatol 21: 105-108
45. Lo WF et al. (2000) Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat Med 6: 215-218
46. Albert LJ and Inman RD (2000) Gram-negative pathogens and molecular mimicry: Is there a case for mistaken identity? Trends Microbiol 8: 444-445
47. Ramos M et al. (2002) Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J Biol Chem 277: 37573-37581
48. Popov I et al. (2001) The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia. J Immunol 167: 3375-3382
49. Popov I et al. (2002) Breakdown of CTL tolerance to self HLA-B*2705 induced by exposure to Chlamydia trachomatis. J Immunol 169: 4033-4038
50. Thomson GT et al. (1995) Post-Salmonella reactive arthritis: Late clinical sequelae in a point source cohort. Am J Med 98: 13-21
51. Sieper J et al. (1999) No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 42: 1386-1396
52. Laasila K et al. (2003) Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis 62: 655-658
53. Smieja M et al. (2001) Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis. Ann Rheum Dis 60: 1088-1094
54. Carter JD et al. (2004) Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 31: 1973-1980
55. Yli-Kerttula T et al. (2000) Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 59: 565-570
56. Yli-Kerttula T et al. (2003) Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis 62: 880-884
57. Kvien TK et al. (2004) Three month treatment of reactive arthritis with azithromycin: A EULAR double blind, placebo controlled study. Ann Rheum Dis 63: 1113-1119
58. Tulassay Z et al. (2001) One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 13: 1457-65
59. Inman, RD and Perl A (2005) Infectious agents in chronic rheumatic diseases. In Arthritis and Allied Conditions 15th Edition, 647-677 (Ed Koopman WJ et al.), Philadelphia
60. Przyklenk B et al. (1990) The role of Campylobacter (Helicobacter) pylori in disorders of the gastrointestinal tract. Infection 18: 3-7